Chemo-endocrine of etoposide and medroxyprogesterone acetate(VMA regimen) in the treatment of heavily pretreated metastastic breast cancer: efficacy and toxicity

doi:10.3969/j.issn.1672-3384.2018.07.005

DAI Zhi-cai,WANG Jia-yu,FAN Ying,XU Bing-he

Clinical Medication Journal ›› 2018, Vol. 16 ›› Issue (7) : 23-27.

PDF(7250 KB)

Clinical Medication Journal ›› 2018, Vol. 16 ›› Issue (7) : 23-27. DOI: 10.3969/j.issn.1672-3384.2018.07.005

Chemo-endocrine of etoposide and medroxyprogesterone acetate(VMA regimen) in the treatment of heavily pretreated metastastic breast cancer: efficacy and toxicity

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2018, 16(7): 23-27 https://doi.org/10.3969/j.issn.1672-3384.2018.07.005

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(7250 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2018-02-26	2018-07-31
Issue Date
2018-07-31

Please choose a citation manager

Content to export